Creative Commons source reading · Traumatic brain injury recovery
Dl-3n-butylphthalide improves traumatic brain injury recovery via inhibiting autophagy-induced blood-brain barrier disruption and cell apoptosis.
Fangfang Wu; Ke Xu; Kebin Xu; Chenhuai Teng; Man Zhang; Leilei Xia; Kairui Zhang; Lei Liu; Zaifeng Chen; Jian Xiao; Yanqing Wu; Hongyu Zhang; Daqing Chen
Originally published in Journal of cellular and molecular medicine · 2019-12-16
From the article
Selected source text. JournalOS removes markup and shortens excerpts where indicated. The full article provides the complete context.
Abstract
Blood-brain barrier (BBB) disruption and neuronal apoptosis are important pathophysiological processes after traumatic brain injury (TBI). In clinical stroke, Dl-3n-butylphthalide (Dl-NBP) has a neuroprotective effect with anti-inflammatory, anti-oxidative, anti-apoptotic and mitochondrion-protective functions. However, the effect and molecular mechanism of Dl-NBP for TBI need to be further investigated. Here, we had used an animal model of TBI and SH-SY5Y/human brain microvascular endothelial cells to explore it. We found that Dl-NBP administration exerts a neuroprotective effect in TBI/OGD and BBB disorder, which up-regulates the expression of tight junction proteins and promotes neuronal survival via inhibiting mitochondrial apoptosis. The expressions of autophagy-related proteins, including ATG7, Beclin1 and LC3II, were significantly increased after TBI/OGD, and which were reversed by Dl-NBP treatment both in vivo and in vitro. Moreover, rapamycin treatment had abolished the effect of Dl-NBP for TBI recovery.
DISCUSSION
Although advances in science and evidence‐based medicine, the mortality and disability of patients with severe TBI has is still high.30 Thus, it is urgent need to find a drug that effectively inhibits the pathological development of TBI in the early stage.2 In the present study, we treated TBI mice with Dl‐NBP and found that Dl‐NBP exerts its neuroprotective effect and promotes the recovery of TBI. Mechanism studies have further observed that the neuroprotective role of Dl‐NBP after TBI was correlated with the down‐regulation of autophagy and consequently ameliorated BBB disorder and neuronal apoptosis.
CONCLUSION
In our current study, we have confirmed that Dl‐NBP has a neuroprotective effect on BBB disorders and neuron apoptosis, and subsequently contributes to motor function recovery. In addition, our data provide evidence that Dl‐NBP down‐regulates TBI/OGD‐induced autophagy and reverses sequential AJ and TJ loss and apoptosis (Figure S1C). However, the molecular mechanism underlying Dl‐NBP inhibiting autophagy remains unclear. In our next study, we will use transgenic mice, such as beclin1−/− or Atg5−/− mice, to deeply reveal the regulatory mechanism underlying it.
Editorial reading guide
- How did the authors define recovery, and when did they measure it?
- Does the outcome reflect a laboratory measure, a functional change or participation in daily life?
